Harpoon Therapeutics, Inc.
Harpoon Therapeutics, Inc. (HARP) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · HARP · as of Jun 9, 2026
Key Statistics
Explore Harpoon Therapeutics, Inc. Data
harp stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 9 · Buy rate: 77.8%
The HARP analyst consensus is Buy, based on ratings from 9 Wall Street analysts over the past 3 months. The average 12-month price target is $700.00, representing +2942.16% upside from the current price of $23.01.
Competitors & Peers
harp competitorsHARP
ALBO
ASLN
CBIO
CDMO
CMRXStock Performance
Full HistoryAbout Harpoon Therapeutics, Inc.
Harpoon Therapeutics, Inc. is a clinical-stage biotechnology firm dedicated to immunotherapy, focused on engineering a novel class of T cell activators. These therapies are designed to leverage the bo…
what is harpoon therapeutics, inc. · harp stock overview · harpoon therapeutics, inc. company profile · who is harpoon therapeutics, inc. ceo · harp NASDAQ · harpoon therapeutics, inc. headquarters · harpoon therapeutics, inc. business segments
About Stock Overview & Key Data
Harpoon Therapeutics, Inc. (HARP) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Feb 8, 2019. As of the latest trading session, HARP stock price is $23.01, with a market capitalization of $865.1M. The stock has returned +257.30% over the past 12 months and +109.18% year-to-date.
According to 9 Wall Street analysts, the consensus rating for Harpoon Therapeutics, Inc. stock is Buy, with an average 12-month price target of $700.00. In fiscal year 2022, Harpoon Therapeutics, Inc. reported revenue of $31.9M and net income of -$67.1M. For detailed data — including Harpoon Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Harpoon Therapeutics, Inc. (HARP) stock price is $23.01. The stock is traded on NASDAQ under the ticker symbol HARP. The 52-week range is $3.11 – $23.21.